Kewalramani Reshma sold VRTX
February 9, 2024 · Form 4 insider transaction
Kewalramani Reshma sold 8,255 shares of Vertex Pharmaceuticals Incorporated at $422.74 per share, a transaction worth $3.49M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,255
Price
$422.74
Total value
$3.49M
InsiderKewalramani Reshma
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 9, 2024
Filing dateFebruary 13, 2024
Shares owned after162,271
OwnershipDirect
10b5-1 planNo
AmendedNo